NASDAQ · Biotechnology

Artelo Biosciences Inc (ARTL)

$1.39 -4.14%
26 Oversold Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$19.99-93.05%

Company profile

Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.

SectorHealthcare
IndustryBiotechnology
Market cap$1.15M
P/E ratioNone
EPS$-130.07
Beta-0.006
Dividend yield0.00%
52-week high$95.04
52-week low$1.91

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for ARTL

An email when ARTL closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 6:13 AM EST